Insulin, IGF-1, and muscarinic agonists modulate schizophrenia-associated genes in human neuroblastoma cells

scientific article

Insulin, IGF-1, and muscarinic agonists modulate schizophrenia-associated genes in human neuroblastoma cells is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.BIOPSYCH.2008.08.031
P698PubMed publication ID18973876
P5875ResearchGate publication ID23441453

P2093author name stringEric Derby
Maree J Webster
Paul Gallagher
Linda W Jurata
C Anthony Altar
Rachel A Hunt
Andrew Lemire
Jeffrey Brockman
Pascal Laeng
P433issue12
P407language of work or nameEnglishQ1860
P921main subjectschizophreniaQ41112
neuroblastomaQ938205
P304page(s)1077-1087
P577publication date2008-10-30
P1433published inBiological PsychiatryQ4914961
P1476titleInsulin, IGF-1, and muscarinic agonists modulate schizophrenia-associated genes in human neuroblastoma cells
P478volume64

Reverse relations

cites work (P2860)
Q30423651A new nosology of psychosis and the pharmacological basis of affective and negative symptom dimensions in schizophrenia.
Q28473511Altered gene synchrony suggests a combined hormone-mediated dysregulated state in major depression
Q35844211Association of VSNL1 with schizophrenia, frontal cortical function, and biological significance for its gene product as a modulator of cAMP levels and neuronal morphology
Q38075505Brain insulin dysregulation: implication for neurological and neuropsychiatric disorders.
Q43158437Clustering of schizophrenia with other comorbidities--what can we learn?
Q36910064Decreased gene expression activity as a result of a mutation in the calreticulin gene promoter in a family case of schizoaffective disorder
Q28256783Dopamine receptors - IUPHAR Review 13
Q60141581Dopamine: Functions, Signaling, and Association with Neurological Diseases
Q33505860Exon expression in lymphoblastoid cell lines from subjects with schizophrenia before and after glucose deprivation.
Q36698123Genetic underpinnings of left superior temporal gyrus thickness in patients with schizophrenia
Q89940643Human insulin modulates α-synuclein aggregation via DAF-2/DAF-16 signalling pathway by antagonising DAF-2 receptor in C. elegans model of Parkinson's disease
Q55668793Implications of Newly Identified Brain eQTL Genes and Their Interactors in Schizophrenia.
Q40277970In vivo evidence of differential impact of typical and atypical antipsychotics on intracortical myelin in adults with schizophrenia
Q37176819Metabolic syndrome in schizophrenia: theoretical, clinical and translational perspectives
Q30451424Neurodevelopmental effects of insulin-like growth factor signaling
Q34178853No paradox, no progress: inverse cancer comorbidity in people with other complex diseases
Q35197367Role of Beta-arrestin 2 downstream of dopamine receptors in the Basal Ganglia.
Q37788537Role of the evolutionarily conserved starvation response in anorexia nervosa
Q33984573S100B Serum Levels in Schizophrenia Are Presumably Related to Visceral Obesity and Insulin Resistance
Q37175279Target identification for CNS diseases by transcriptional profiling.
Q33510901Thalamic transcriptome screening in three psychiatric states

Search more.